Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase it...

The Dengue Alliance, a coalition of institutions from dengue-endemic countries, plans to develop a new treatment for dengue within five yea...

Neglected tropical diseases (NTDs) continue to pose a significant health burden on some of the most disadvantaged communities in India, acc...

According to the World Health Organization, dengue represents one of the 10 biggest global health threats and it is critical to have access...

The IPCC has come out with a special report on global warming that said limiting it to 1.5 degrees Celsius will require rapid, far-reaching...

Researchers observed that except for Gujarat which comprises of arid regions, there was a strong correlation between rainfall and dengue di...

Under its latest Memorandum of Understanding (MoU), ICMR will be focussed on research and development of vaccines combatting various infect...

While details of the structure are yet to be chalked out, the group has so far considered prioritising infectious diseases like dengue and ...

The ICGEB plans a larger vaccine trial on monkeys in America; the full-fledged human trial after that could cost more than Rs 100 crore.

Dengue imposes a whopping $8.9 billion economic burden every year on 141 countries and territories where active transmission of the disease...

Estimates of the UN agency show incidence of dengue alone has risen 30-fold worldwide over the last few decades resulting in a huge socio-e...

The injection can thwart all four types of the virus, which has appeared in Portugal, France, Florida and Japan recently, according to WHO.

India is setting up a network of high-tech viral diagnostic laboratories across the country to find out the real burden of dengue and simil...

Country Head, Sanofi Pasteur, Stephan Barth, said dengue is a serious health concern in India, causing a significant but under-reported bur...

The study showed that 87% of Indian adults in trial were positive to dengue at enrolment, confirming the significant endemic nature of the ...

"Good data on the incidence and cost of the illness have been lacking due to gaps in how information on individual cases is collected."

Given the state of affairs, the Economic Survey’s recommendations on healthcare might sound like truisms. But then, the truth does need to ...